Drug intelligence / Profile preview

miR-150

Development stage
Preclinical
Lead developer
Fred Hutchinson Cancer Research Institute
Modality
RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous
01

Overview

miR-150 is a microRNA that acts as a key regulator of hematopoietic lineage differentiation. In myeloid leukemias, including acute myeloid leukemia (AML) and chronic myeloid leukemia (CML), miR-150 expression is frequently downregulated, which contributes to the characteristic block in myeloid cell maturation. Therapeutic strategies involving miR-150 aim to restore its levels to induce differentiation and inhibit leukemic cell growth. The primary mechanism of action for miR-150 is the post-transcriptional repression of the MYB transcription factor, a protein essential for maintaining the proliferative state of hematopoietic progenitor cells. By binding to the 3-UTR of MYB mRNA, miR-150 reduces its expression, thereby promoting the transition from a progenitor state to a differentiated myeloid cell.

Other names
hsa-miR-150hsa-miR150hsa-miR 150microRNA-150microRNA150microRNA 150
02

Targets

ATF5MYB (Proto-oncogene protein c-myb)IRF8 (Interferon regulatory factor 8)

Beyond the preview

Go deeper on miR-150.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-150.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call